ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OMDA vs TDOC // NET PROFIT MARGIN

Omada Health Inc. (NASDAQ) VS. Teladoc Health Inc. (NYSE) • 15-METRIC TALLY: OMDA 5 — TDOC 3
▲ NET PROFIT MARGIN LEADER: OMDA
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OMDA VS. TDOC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OMDA TDOC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 65.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -15.70% -17.00% +1.30 OMDA /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 1.41% 18.00% -16.59 TDOC /fcf-yield <GO>
Operating Margin -4.60% -10.40% +5.80 OMDA /operating-margins <GO>
Net Profit Margin ACTIVE -4.90% -7.90% +3.00 OMDA /net-margins <GO>
Revenue Growth (YoY) 53.20% -1.50% +54.70 OMDA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.93 0.45 +8.48 OMDA /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.5 74.1 -29.60 TDOC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 32.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.15B $1.55B -$404.7M TDOC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OMDA REV TDOC REV OMDA GROSS % TDOC GROSS % OMDA FCF TDOC FCF
FY 2025 $260.2M $2.53B 65.7% — $16.9M $285.5M
FY 2024 $169.8M $2.57B 60.6% — -$34.8M $282.9M
FY 2023 $122.8M $2.60B — — -$49.7M $232.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OMDA // BETA —
TDOC // BETA 1.08